Bright Minds Biosciences Inc. (CSE:DRUG)
Canada flag Canada · Delayed Price · Currency is CAD
33.64
-3.04 (-8.29%)
Jun 27, 2025, 12:14 PM EDT

Bright Minds Biosciences Ratios and Metrics

Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2019
2747828107-
Upgrade
Market Cap Growth
5462.49%-19.09%-71.17%-73.71%--
Upgrade
Enterprise Value
219001985-
Upgrade
Last Close Price
38.731.472.158.5045.20-
Upgrade
PB Ratio
4.921.191.232.675.51-
Upgrade
P/TBV Ratio
4.921.191.232.675.52-
Upgrade
Debt / Equity Ratio
0.000.020.010.01--
Upgrade
Quick Ratio
87.6410.9224.168.0031.125.30
Upgrade
Current Ratio
88.2711.3224.268.1131.385.82
Upgrade
Return on Equity (ROE)
-11.21%-46.18%-86.02%-99.95%-85.94%-124.04%
Upgrade
Return on Assets (ROA)
-10.57%-25.19%-47.45%-57.32%-51.52%-61.70%
Upgrade
Return on Capital (ROIC)
-10.80%-26.53%-51.86%-61.21%-53.54%-76.64%
Upgrade
Earnings Yield
-1.26%-42.70%-90.90%-53.20%-8.09%-
Upgrade
Buyback Yield / Dilution
-39.99%-15.87%-50.58%-37.64%-148.42%-74.24%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.